Xavier; Ramnik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xavier; Ramnik.The latest application filed is for "uses of salt-inducible kinase (sik) inhibitors for treating osteoporosis".

Company Profile

16.5.24

Xavier; Ramnik - Brookline MA
Xavier; Ramnik - Boston MA
Xavier; Ramnik - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis App 20220305016 - Wein; Marc ; et al.	2022-09-29
Systems And Methods For Mhc Class Ii Epitope Prediction App 20220293215 - Xavier; Ramnik ; et al.	2022-09-15
Compositions and methods for treating inflammatory bowel disease Grant 11,382,908 - Leshchiner , et al. July 12, 2	2022-07-12
Compositions And Methods For Modulating Cgrp Signaling To Regulate Intestinal Innate Lymphoid Cells App 20220143148 - Regev; Aviv ; et al.	2022-05-12
Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity Grant 11,285,144 - Sundberg , et al. March 29, 2	2022-03-29
Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Grant 11,241,435 - Wein , et al. February 8, 2	2022-02-08
Cell Atlas Of The Healthy And Ulcerative Colitis Human Colon App 20210325387 - Shalek; Alexander K. ; et al.	2021-10-21
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20210147425 - Gray; Nathanael S. ; et al.	2021-05-20
Cholesterol Reducing Compositions And Methods Of Use Thereof App 20210128642 - KENNY; Douglas ; et al.	2021-05-06
Bicyclic urea kinase inhibitors and uses thereof Grant 10,954,242 - Gray , et al. March 23, 2	2021-03-23
Methods For Identification Of Genes And Genetic Variants For Complex Phenotypes Using Single Cell Atlases And Uses Of The Genes And Variants Thereof App 20210071255 - Regev; Aviv ; et al.	2021-03-11
Modulation Of Epithelial Cell Differentiation, Maintenance And/or Function Through T Cell Action, And Markers And Methods Of Use Thereof App 20210040442 - Rajagopal; Jayaraj ; et al.	2021-02-11
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20200338087 - Shamji; Alykhan ; et al.	2020-10-29
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20200317675 - GRAY; Nathanael S. ; et al.	2020-10-08
Compositions And Methods For Treating Inflammatory Bowel Disease App 20200268736 - Leshchiner; Elizaveta ; et al.	2020-08-27
Compositions And Methods For Treating Inflammatory Bowel Diseases App 20200246488 - Kind Code	2020-08-06
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis App 20200179387 - Wein; Marc ; et al.	2020-06-11
Methods Of Treating And Diagnosing Ibd Associated With R. Gnavus And/or R. Gnavus Group Ibd Colonization App 20200155617 - Hall; Andrew Brantley ; et al.	2020-05-21
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20190343842 - Shamji; Alykhan ; et al.	2019-11-14
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20190315752 - GRAY; Nathanael S. ; et al.	2019-10-17
Modulation Of Intestinal Epithelial Cell Differentiation, Maintenance And/or Function Through T Cell Action App 20190263912 - Haber; Adam ; et al.	2019-08-29
Use Of Cdk8 Inhibitors To Treat Diseases Of Inflammation And Autoimmunity App 20190183881 - Sundberg; Thomas ; et al.	2019-06-20
Uses of salt-inducible kinase (SIK) inhibitors Grant 10,265,321 - Shamji , et al.	2019-04-23
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20180221379 - Shamji; Alykhan ; et al.	2018-08-09
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20170224700 - Shamji; Alykhan ; et al.	2017-08-10
Pdz Domain Interactions And Lipid Rafts App 20100215677 - Lu; Peter S. ; et al.	2010-08-26
Pdz Domain Interactions And Lipid Rafts App 20080166736 - Lu; Peter S. ; et al.	2008-07-10
PDZ domain interactions and lipid rafts App 20030049695 - Lu, Peter S. ; et al.	2003-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.